News

Published on 8 Nov 2024 on Zacks

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract


Article preview image

AMN Healthcare's dismal results in the majority of its segments led to a soft overall third-quarter...

NYSE.RMD price evolution
NYSE.DGX price evolution
NYSE.AMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst...

Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be...

Simply Wall St. · via Yahoo Finance 18 Dec 2024

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Rank and Key Picks ZBH currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the...

Zacks · via Yahoo Finance 16 Dec 2024

Why ResMed (RMD) is a Top Value Stock for the Long-Term

Utilizing ratios like P/E, PEG, Price/Sales, and Price...Flow, the Value Style Score identifies t...

Zacks · via Yahoo Finance 13 Dec 2024

Zacks.com featured highlights include InterDigital, ResMed, Greenbrier...

December 13, 2024 – Stocks in this week’s article are InterDigital, Inc. (IDCC Quick QuoteIDCC -...

Zacks 13 Dec 2024

Top Research Reports for Berkshire Hathaway, Exxon Mobil & Novo Nordisk

Today's Research Daily features new research reports on 16 major stocks, including Berkshire...

Zacks · via Yahoo Finance 6 Dec 2024

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why This 1 Growth Stock Should Be On Your Watchlist For growth investors, a company...like projec...

Zacks · via Yahoo Finance 6 Dec 2024

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

The expansion of gross and operating margins on a reported basis bodes well for the stock. Improv...

Zacks · via Yahoo Finance 6 Dec 2024

ResMed (RMD) Rose 15% in Q3

Fidelity Investments, an investment management company, recently released its “Fidelity Growth St...

Insider Monkey · via Yahoo Finance 6 Dec 2024

ResMed director Peter C. Farrell sells $491,300 in stock By Investing.com

ResMed, with a market capitalization of $35.1 billion, has demonstrated strong performance with a...

Investing.com 6 Dec 2024

ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company...

Zacks · via Yahoo Finance 5 Dec 2024